We are a pioneering TechBio team using our LITOSeek™ AI-RNA platform to deliver liquid biopsy multi-omic solutions that improve patient outcomes.
We are on a mission to revolutionize cancer care through early detection and targeted therapy development.
We’re transforming cancer care with proven precision medicine breakthroughs.
Novigenix has been ISO 13485:2016 certified by BSI since September 2024, demonstrating our commitment to maintaining the highest standards in quality management systems for medical devices. This certification ensures that our products and services meet regulatory requirements and consistently deliver safe, reliable healthcare solutions. Our ISO 13485 certificate is available upon request—please contact us at qa@novigenix.com for more information.
At Novigenix, we prioritize data protection and privacy in accordance with GDPR regulations. Our commitment to safeguarding personal data ensures that we handle information with the utmost care and transparency. This compliance reinforces our dedication to ethical practices and customer trust in our services. For more details about our GDPR compliance, please feel free to reach out to us at dpo@novigenix.com.
Novigenix is committed to staying abreast of latest security technologies and adhering to all regulatory measures. Ongoing extension of our certification to ISO 27001 will further document all processes to the highest industry standard and guarantee continuous implementation of best data security practices and policies.
Novigenix data security measures include:
